Orega Biotech Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $1.38M
Latest Deal Amount
  • Investors
  • 6

Orega Biotech General Information

Description

Developer of cancer immunology therapies designed to develop monoclonal antibodies for cancer immunotherapy. The company's immunology therapies deal in innovative therapeutic strategies in the field of cancer, focus on tumor microenvironment and also develops antibodies for modulating regulatory T cells activities in cancer, providing doctors with improved anticancer strategies, response rates and patient survival

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Espace Européen Bât G
  • 15 chemin du Saquin
  • 69130 Ecully
  • France
+33 04 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orega Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 13-May-2014 $1.38M 00.000 Completed Startup
2. Early Stage VC 01-Sep-2010 00.00 00.00 Completed Startup
1. Accelerator/Incubator 01-Mar-2010 Completed Startup
To view Orega Biotech’s complete valuation and funding history, request access »

Orega Biotech Executive Team (5)

Name Title Board Seat Contact Info
Gilles Alberici Ph.D Co-Founder, Chief Executive Officer & Chairman
Nathalie Bonnefoy Ph.D Co-Founder & Chief Scientific Officer
Armand Bensussan Ph.D Co-Founder & Scientific Advisor
Jean-François Eliaou Ph.D Co-Founder & Scientific Advisor
Jeremy Bastid Ph.D Chief Operating Officer
To view Orega Biotech’s complete executive team members history, request access »

Orega Biotech Board Members (3)

Name Representing Role Since
Bervin Bouani Orega Biotech Board Member 000 0000
Gilles Alberici Ph.D Orega Biotech Co-Founder, Chief Executive Officer & Chairman 000 0000
Isabelle Bou Antoun Rhône-Alpes Création Board Member 000 0000
To view Orega Biotech’s complete board members history, request access »

Orega Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orega Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Inserm Transfert Venture Capital Minority 000 0000 000000 0
Kreaxi Venture Capital Minority 000 0000 000000 0
Rhône-Alpes Création Venture Capital Minority 000 0000 000000 0
Sham Corporation Minority 000 0000 000000 0
OCTALFA Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »